Surface Oncology, Inc.
SURF · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $30,000 | $2,687 | $126,162 | $15,360 |
| % Growth | 1,016.5% | -97.9% | 721.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $30,000 | $2,687 | $126,162 | $15,360 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $67,003 | $53,572 | $41,018 | $52,118 |
| G&A Expenses | $24,866 | $25,128 | $23,558 | $20,608 |
| SG&A Expenses | $24,866 | $25,128 | $23,558 | $20,608 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $74 | $0 | $0 |
| Operating Expenses | $91,869 | $78,700 | $64,576 | $72,726 |
| Operating Income | -$61,869 | -$76,013 | $61,586 | -$57,366 |
| % Margin | -206.2% | -2,828.9% | 48.8% | -373.5% |
| Other Income/Exp. Net | -$1,717 | -$2,472 | -$2,249 | $2,577 |
| Pre-Tax Income | -$63,586 | -$78,485 | $59,337 | -$54,789 |
| Tax Expense | $1,717 | $977 | $0 | -$1,785 |
| Net Income | -$65,303 | -$79,462 | $59,337 | -$53,004 |
| % Margin | -217.7% | -2,957.3% | 47% | -345.1% |
| EPS | -1.17 | -1.8 | 1.67 | -1.9 |
| % Growth | 35% | -207.8% | 187.9% | – |
| EPS Diluted | -1.17 | -1.8 | 1.57 | -1.9 |
| Weighted Avg Shares Out | 55,761 | 44,243 | 38,142 | 27,855 |
| Weighted Avg Shares Out Dil | 55,761 | 44,243 | 38,142 | 27,855 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2,577 |
| Interest Expense | $1,717 | $2,472 | $2,249 | $0 |
| Depreciation & Amortization | $1,368 | $1,569 | $1,670 | $1,785 |
| EBITDA | -$61,869 | -$76,013 | $61,586 | -$57,366 |
| % Margin | -206.2% | -2,828.9% | 48.8% | -373.5% |